#cingulate
Latest news and interesting information about cingulate.
Cingulate Reports Q1 Loss
Cingulate Q1 2026 results: net loss $9.3M, cash at $25.9M. ADHD drug candidate CTx-1301 advances with FDA.
...
Latest news and interesting information about cingulate.